canrenone has been researched along with HIV Coinfection in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, P; Bushman, L; Castro, CRV; Cattani, VB; Eksterman, L; Estrela, R; Grinsztejn, B; Jalil, EM; Monteiro, L; Torres, T; Veloso, VG; Wagner Cardoso, S; Wilson, E | 1 |
1 trial(s) available for canrenone and HIV Coinfection
| Article | Year |
|---|---|
Estradiol and Spironolactone Plasma Pharmacokinetics Among Brazilian Transgender Women Using HIV Pre-Exposure Prophylaxis: Analysis of Potential Interactions.
Topics: Adult; Anti-HIV Agents; Brazil; Canrenone; Estradiol; Female; HIV Infections; Humans; Male; Spironolactone; Transgender Persons; Young Adult | 2023 |